ArticleMedicina (Kaunas, Lithuania)2026
A Comparative Study of Different Biological Drugs in First-Line Therapy in Crohn's Disease: A Multicenter Descriptive Analysis.
Andrei Gila, Carmen Monica Preda, Mircea Diculescu, Razvan Matei Bratu, Doina Istratescu, Tudor Stroie, Anca Trifan, Alina Tantau, Sandica Bucurica, Cristian George Tieranu and 5 more
Abstract readMulticenter StudyComparative Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Andrei GilaGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Carmen Monica PredaGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Mircea DiculescuGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Razvan Matei BratuAnatomy Department, UMF "Carol Davila", 0200201 Bucharest, Romania.
Doina IstratescuGastroenterology & Hepatology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Tudor StroieGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Anca TrifanDepartment of Gastroenterology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.ORCID 0000-0001-9144-5520 Sandica BucuricaGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.ORCID 0000-0002-8787-3829 Cristian George TieranuGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.ORCID 0000-0001-5348-0341 Horia MineaDepartment of Gastroenterology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.ORCID 0000-0002-7736-8140 Ana Maria BuzuleacDepartment of Gastroenterology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
Lucian NegreanuGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.ORCID 0000-0003-3042-0754 Remus PopescuGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Cosmin Alexandru CioraGastroenterology & Hepatology Department, UMF "Carol Davila", 020021 Bucharest, Romania.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Biological FactorsBiological ProductsCrohn DiseaseAdalimumabAdultFemaleHumansInfliximabMaleMiddle AgedTreatment OutcomeUstekinumabAdalimumabBiological FactorsBiological ProductsInfliximabUstekinumabadalimumabbiologic therapyCrohn’s diseasefirst-line therapyinfliximabreal-world datatreatment sequencingustekinumab
Identifiers
PMID42195154
PMCPMC13208934
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390